ELORES is contraindicated in patients with known hypersensitivity to β-lactam antibiotics. In patients hypersensitive to penicillin, the possibility of allergic cross-reactions should be borne in mind. Elores 1.5 g strength is not recommended for patients below 18 years specially Hyperbilirubinaemic newborns and preterm newborns should not be treated with ceftriaxone-Sulbactam powder for infusion. In vitro studies have shown that ceftriaxone can displace bilirubin from its binding to serum albumin and bilirubin encephalopathy can possibly develop in these patients, though studies with Ceftriaxone have proved improved safety with significantly lesser encephalopathy. But, as a precautionary measure ELORES should be avoided or taken with extra caution.